CR at these level is pathetic imo. Been a very disappointing stock. Not worth the sellnow just hang in there and hope for the best. So muchpotential and opportunity. Maybe come back in 3 yearsand see what has transpired with this one.GLA.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025